Piramal Enterprises Ltd

Ticker: PEL
Decent 68/100

☆ Add to Watchlist

Investing Reference

Price
1124.20
Market Cap
25320.71
Debt/Equity
2.4202
ROE %
1.810
PB
0.9345
Promoter %
46.161
Pledge %
0.000
1Y Rev Growth %
4.030
5Y Rev Growth %
-5.971
NP Margin %
4.516
NP Margin 5Y Avg %
15.122

Trading Reference

1M Return %
-3.328
6M Return %
9.909
1Y Return %
4.752
% Away 52W High
20.557
% Away 52W Low
32.532
Daily Volume
2148582
Investment Verdict
Hold
Score 70/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 18/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

More Options

Business Overview

Piramal Enterprises Ltd is a diversified global conglomerate based in India, operating across pharmaceuticals, financial services, and real estate. With a commitment to innovation and sustainability, it caters to a wide range of stakeholders, including healthcare providers, investors, and real estate developers. The company's strong legacy and strategic investments make it a significant player in the Indian market, driving growth and creating value for its shareholders.

  • Established leader in pharmaceuticals and financial services
  • Focus on innovation and sustainable practices
  • Strong presence in real estate development
  • Robust growth trajectory and strategic investments
  • Commitment to enhancing stakeholder value

Investment Thesis

Piramal Enterprises Ltd stands out as a compelling investment opportunity due to its strong promoter credibility, robust growth potential in digital services, and attractive valuation compared to peers. The company's strategic initiatives position it well for future growth, making it a noteworthy addition to any portfolio.

  • Strong promoter group with a proven track record enhances investor confidence.
  • Significant growth potential in digital services sector, tapping into evolving market demands.
  • Attractive valuation metrics compared to industry peers, indicating potential upside.
  • Diversified business model reduces risk and enhances revenue streams.
  • Strategic investments and partnerships bolster future growth prospects.

Opportunity vs Risk

Opportunities
  • Strong growth in healthcare sector
  • Diversification into new business areas
  • Potential for strategic acquisitions
  • Rising demand for consumer products
Risks ⚠️
  • High debt levels
  • Regulatory changes affecting operations
  • Market competition intensifying
  • Economic slowdown impacts performance

Peer Perspective

Piramal Enterprises trades at a discount to peers like Sun Pharmaceutical and Dr. Reddy's Laboratories, reflecting concerns over margin stability. A clear path to consistent growth could trigger a rerating in its valuation.
📊 Stock Investment Checklist (100 Points)
Piramal Enterprises Ltd • Updated: 2025-09-17 15:06:38
  • 10
    Business
    High
    The sector is evolving with a focus on healthcare and financial services, but faces competition.
  • 10
    Growth
    High
    Revenue growth has been inconsistent, with some fluctuations in profit margins.
  • 10
    Profitability
    High
    ROE and ROCE are moderate, with operating cash flow showing some volatility.
  • 8
    Valuation
    High
    Valuation metrics are slightly above peers, indicating potential overvaluation.
  • 7
    Balance
    High
    Debt levels are manageable, but liquidity ratios need improvement.
  • 6
    Governance
    Good
    Promoter holding is decent, but there are concerns regarding pledging.
  • 5
    Drivers
    Good
    Growth drivers exist, but execution risks are significant.
  • 5
    Technicals
    Good
    Market sentiment is mixed, with low liquidity impacting price action.
Final Score & Verdict
Score 68 / 100 • Decent
Piramal Enterprises has potential but faces challenges in growth consistency and market valuation.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 75/100
  • Growth Potential: 70/100
  • Profitability: 65/100
  • Governance: 80/100
  • Market Confidence: 72/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.